Introduction {#Sec1}
============

The appendix of the second edition of the International Classification of Headache Disorders (ICHD-2) from 2004 describes two types of migraine without aura (MO) related to menstruation: pure menstrual migraine (PMM) and menstrually related migraine (MRM) \[[@CR1]\]. Those with PMM have MO attacks exclusively in relation to at least two thirds of their menstrual periods, while those with MRM additionally experience MO attacks outside the menstrual period. Before the ICHD-2 classification, researchers had no specific guidelines for the definition of menstrual migraine. The first classification of the International Headache Society from 1988 did not classify menstrual migraine as a specific type of headache, but had a comment in relation to MO: "Migraine without aura may occur almost exclusively at a particular time of the menstrual cycle---so-called menstrual migraine. Generally accepted criteria for this entity are not available. It seems reasonable to demand that 90% of attacks should occur between 2 days before menses and the last day of menses, but further epidemiological knowledge is needed" \[[@CR2]\]. The latter definition encompasses only a few of those with MRM. A recent epidemiological survey suggests that 21% of women with migraine have menstrual migraine, and about two thirds have MRM \[[@CR3]•\]. These circumstances make the literature on menstrual migraine heterogenous, which one should bear in mind in the current analysis of symptomatology of menstrual and nonmenstrual migraine attacks. To complicate matters, what about migraine with aura (MA)? About one third of all migraineurs have MA \[[@CR4]\]. An epidemiological survey implies that headache in attacks of MO may be slightly more severe than headache in attacks of MA \[[@CR5]\], but it seems that MA is not associated with menstruation on the same scale as MO. In fact, MA may be unrelated to menstruation \[[@CR6]\].

The most precise information on migraine attacks is ascertained from prospective recording (ie, headache diaries with detailed information about pain characteristics, accompanying symptoms, duration, and treatment). Such data may not be generalizable because keeping a headache diary for a longer period is not applicable for a large population due to low compliance. In contrast, retrospective data from large population-based studies may be generalizable, but the detailed information about migraine attacks is subject to memory bias. Thus, a combination of prospective and retrospective data is likely to give the most precise description of the migraine attacks.

This review analyzes the literature to enlighten whether menstrual and nonmenstrual migraine attacks are different, given the methodological challenges mentioned above.

Menstrual Versus Nonmenstrual Migraine Attacks {#Sec2}
==============================================

Attack Frequency {#Sec3}
----------------

A Danish epidemiological survey based on 18-- to 65-year-old people from the general population, including a direct clinical interview and a physical and neurological examination by a physician, found that less than 10% of women with MO had more than one MO attack per month \[[@CR5]\].

Thus, the vast majority (ie, ≥90%) of all women with migraine have 1 or fewer MO attacks per month. Some of those with PMM will have 1 MO attack per month, while most patients with MRM have more than 1 MO attack per month. Thus, the MO attack frequency is much higher in most women with PMM or MRM than in those with nonmenstrual MO. Although this does not address whether menstrual and nonmenstrual MO attacks are different, it indicates that those with menstrual MO are likely to have a higher disease burden than most women with nonmenstrual MO.

Attack Severity {#Sec4}
---------------

### Pain Characteristics {#Sec5}

Table [1](#Tab1){ref-type="table"} shows attack characteristics of menstrual migraine in relation to nonmenstrual migraine. Two studies from the general population suggest that the pain intensity is higher in menstrual than nonmenstrual MO \[[@CR7], [@CR8]\]. Studies on clinic populations provide conflicting results; four studies are in support of the findings in the general population, while four studies suggest similar pain intensity and one study missed information on pain intensity \[[@CR9]--[@CR15], [@CR16]•, [@CR17]•\]. Table 1Attack characteristics of menstrual migraine in relation to nonmenstrual migraineStudyPopulationCountry, YearDesignPain intensityAssociated symptomsDurationDisabilityTreatmentStewart et al. \[[@CR7]\]GeneralUSA, 200081 women filled in diary for 98 daysSlightly higher pain intensity during the first 2 days of menstruationNo differenceSimilar durationEqually disablingNRCouturier et al. \[[@CR8]\]GeneralThe Netherlands, 20021,181 women (13--55 y) replied on a questionnaireMore painfulNRLonger durationMore disablingMore treatment resistantSilberstein et al. \[[@CR9]\]ClinicUSA, 200295 womenSimilar pain intensityNRNRNRRizatriptan gave equal pain relief (78%) after 2 hGranella et al. \[[@CR10]\]ClinicItaly, 200464 women filled in diary for 2 monthsSimilar pain intensityNo differenceSignificantly longer duration, more frequent status migrainosusSignificant higher work-related disabilityMore treatment resistant (lower 2-hour pain-free response, lower sustained pain-free response, higher recurrence)MacGregor et al. \[[@CR11]\]ClinicUK, 2004155 women (15--58 y) filled in diaryMore painfulMore nausea and vomitingNRNRNRMartin et al. \[[@CR12]\]ClinicUSA, 200521 women filled in diary for 3 menstrual cyclesSignificant higher headache index during menstruationNRNRHigher disability indexNRDowson et al. \[[@CR13]\]ClinicUK, 200530 women from general practices filled in a questionnaireNRNRNRSignificant more time with \<50% productivityNRMacGregor et al. \[[@CR14]\]ClinicUK, 200638 women (29--50 y) filled in a diaryMore painfulMore nausea and vomitingNRNRNRDiamond et al. \[[@CR15]\]ClinicUSA, 2008190 women in a multicenter, double-blind, parallel-group trial (post hoc analysis)Similar pretreatment pain intensityNo differenceNRSimilar pretreatment disabilityAlmogran gave similar pain relief after 2 h, pain-free response after 2 h, and sustained pain-freePinkerman et al. \[[@CR16]•\]ClinicUSA, 2010107 women not receiving migraine prophylaxis filled in a diaryMore painfulNo differenceLonger duration higher recurrence within 24 h. Attacks \>72 h were twice as frequentMore disablingLess pain-free response at 2 h; higher recurrence within 24 h; used more doses of triptans per migraine attack and rescue medication required more oftenMacGregor et al. \[[@CR17]•\]ClinicUSA, 2010153 women (\>18 y) in a 2-month multicenter, open-label study (post hoc analysis)Similar pain intensityNRLonger durationHigher functional impairmentMore likely to relapse*NR* not reported

### Associated Symptoms {#Sec6}

The study based on prospective filled-in diaries from the general population suggests no significant difference in associated symptoms in attacks of menstrual and nonmenstrual migraine \[[@CR7]\]. This is supported by three studies based on clinic populations \[[@CR10], [@CR15], [@CR16]•\]. However, two clinic studies based on prospective filled-in diaries suggest that menstrual migraine attacks are accompanied by more nausea and vomiting than nonmenstrual attacks \[[@CR11], [@CR14]\].

### Duration {#Sec7}

The study based on prospective filled-in diaries from the general population suggests that attacks of menstrual and nonmenstrual migraine have similar duration \[[@CR7]\]. In contrast, all the other studies suggest that attacks of menstrual migraine are longer than attacks of nonmenstrual migraine, including data based on prospective filled-in diaries \[[@CR8], [@CR10], [@CR16]•, [@CR17]•\].

### Disability {#Sec8}

The study based on prospective filled-in diaries from the general population and one clinic study suggest that attacks of menstrual and nonmenstrual migraine have similar disability \[[@CR7], [@CR15]\]. In contrast, all the other studies suggest that attacks of menstrual migraine are more disabling than attacks of nonmenstrual migraine, including data based on prospective filled-in diaries \[[@CR8], [@CR10], [@CR12], [@CR13], [@CR16]•, [@CR17]•\].

### Treatment {#Sec9}

Two clinical trials on rizatriptan and almotriptan suggest equal efficacy on pain relief 2 h post-treatment of menstrual and nonmenstrual migraine attacks \[[@CR9], [@CR15]\]. Other studies suggest that attacks of menstrual migraine are more treatment resistant than attacks of nonmenstrual migraine \[[@CR8], [@CR10], [@CR16]•\] or that menstrual migraine attacks are more likely to relapse \[[@CR17]•\].

Conclusions {#Sec10}
===========

The question whether menstrual and nonmenstrual migraine attacks are different unfortunately cannot be answered unambiguously because previous studies provide conflicting results. This is mainly due to different patient populations, unequal definitions of menstrual migraine, and different methods employed.

Future studies should focus on the general population to provide generalizable data, in contrast to possibly skewed data from selected clinic populations. Prospective recordings should be employed, combined with retrospective data on the headache history. To provide precise headache diagnoses, interviews by a trained physician or neurologist with special interest in headache is the gold standard. Such a study is likely to more firmly answer whether menstrual and nonmenstrual migraine attacks are different.
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